Patents/Inventors

Wenqing Yao

Wilmington, DEUS67 patents

72 Patents

US126007172026
Tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US125522622026
Economical Optimization Strategy Construction Method for Lateral Stability Control of Electric Vehicle
ANHUI UNIVERSITY
0 cites
US125528042026
Tricyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US125344632026
Substituted Tricyclic Compounds as FGFR Inhibitors
Incyte Holdings Corporation
0 cites
US124668152025
Carboxamide Compounds and Uses Thereof
Incyte Corporation
0 cites
US124668222025
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US124668282025
Bicyclic Amines as CDK2 Inhibitors
Incyte Corporation
0 cites
US124417272025
Tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US124417312025
Pyrazolopyrimidine Compounds and Uses Thereof
Incyte Corporation
0 cites
US124417422025
Naphthyridine Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US124284202025
Tricyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US123847782025
Pyrazolopyridine Compounds and Uses Thereof
Incyte Corporation
0 cites
US123782432025
Quinoline Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US123310632025
Hetero-bicyclic Inhibitors of KRAS
Incyte Corporation
0 cites
US123123312025
Imidazolyl Pyrimidinylamine Compounds as CDK2 Inhibitors
Incyte Corporation
0 cites
US122470262025
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US122470382025
Pyrido[3,2-d]pyrimidine Compounds as Immunomodulators
Incyte Corporation
0 cites
US122016362025
Heterocyclylamines as PI3K Inhibitors
Incyte Holdings Corporation
0 cites
US121877252025
Tricyclic Urea Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US121877432025
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US121292672024
Heteroaryl Amide Compounds as Sting Activators
Incyte Corporation
0 cites
US121227672024
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US120831242024
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US120844492024
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
INCYTE CORPORATION
0 cites
US120775392024
Imidazole and Triazole KRAS Inhibitors
Incyte Corporation
0 cites
US120604332024
CD73 Inhibitor and A2A/A2B Adenosine Receptor Inhibitor Combination Therapy
Incyte Corporation
0 cites
US120308832024
Hetero-tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US120308842024
Pyrazoloquinoline KRAS Inhibitors
Incyte Corporation
0 cites
US120308892024
Imidazopyridazine and Imidazopyridine Compounds and Uses Thereof
Incyte Corporation
0 cites
US120124092024
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US119997402024
Fused Pyrazine Derivatives as A2A / A2B Inhibitors
Incyte Corporation
0 cites
US119997522024
Vinyl Imidazole Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US119588612024
Spirocyclic Lactams as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US119393282024
Quinoline Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US119393312024
Tricyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US119199042024
Sulfonylamide Compounds as CDK2 Inhibitors
Incyte Corporation
0 cites
US119199082024
Substituted Pyrrolo[2,3-d]pyrimidine Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US119127222024
Tricyclic Heteroaryl Compounds as Sting Activators
Incyte Corporation
0 cites
US118978912024
Tricyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US118913882024
Pyrazolopyridine Compounds and Uses Thereof
Incyte Corporation
0 cites
US118733042024
Fused Pyrimidine Derivatives as A2A/A2B Inhibitors
Incyte Corporation
0 cites
US118733092024
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US118664262024
Benzothiazole Compounds and Uses Thereof
Incyte Corporation
0 cites
US118664322024
Dihydropyrido[2,3-d]pyrimidinone Compounds as CDK2 Inhibitors
Incyte Corporation
0 cites
US118664352024
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US118514262023
Bicyclic Amines as CDK2 Inhibitors
Incyte Corporation
0 cites
US118405342023
Substituted Tricyclic Compounds as FGFR Inhibitors
Incyte Holdings Corporation
0 cites
US118405462023
Imidazopyridazine Compounds and Uses Thereof
Incyte Corporation
0 cites
US117951662023
Pyrazolopyridine Compounds and Uses Thereof
Incyte Corporation
0 cites
US117877932023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US117808402023
Tricyclic Urea Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US117673202023
Bicyclic Dione Compounds as Inhibitors of KRAS
INCYTE CORPORATION
0 cites
US117673232023
Tricyclic Pyridone Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US117534132023
Substituted Pyrrolo[2,1-f][1,2,4]triazine Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US117391022023
Fused Pyrimidine Compounds as KRAS Inhibitors
INCYTE CORPORATION
0 cites
US117319582023
Carboxamide Compounds and Uses Thereof
Incyte Corporation
0 cites
US117186052023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US117133172023
Tricyclic Heterocyclic Compounds as Sting Activators
Incyte Corporation
0 cites
US116919712023
Naphthyridinone Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US116738832023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US116738942023
Imidazopyrimidines and Triazolopyrimidines as A2A / A2B Inhibitors
Incyte Corporation
0 cites
US116676352023
Bicyclic Heterocycles as FGFR4 Inhibitors
Incyte Holdings Corporation
0 cites
US116614222023
Tricyclic Urea Compounds as JAK2 V617F Inhibitors
Incyte Corporation
0 cites
US116135362023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US116074162023
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US116083372023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US115966922023
PD-L1/STING Conjugates and Methods of Use
Incyte Corporation
0 cites
US115913292023
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US115723662023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US115660262023
Heterocyclic Compounds as Immunomodulators
Incyte Corporation
0 cites
US115660282023
Bicyclic Heterocycles as FGFR Inhibitors
Incyte Corporation
0 cites
US115422652023
Pyrazolopyrimidine Compounds and Uses Thereof
Incyte Corporation
0 cites